All Stories

  1. Is rapamycin a rapalog?
  2. Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms
  3. Short-term consumption of a plant protein diet does not improve glucose homeostasis of young C57BL/6J mice
  4. Interleukin 6 protects pancreatic β cells from apoptosis by stimulation of autophagy
  5. mTORC2 Puts Its Shoulder to Krebs’ Wheel
  6. Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health
  7. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer
  8. Pancreatic β-Cells From Mice Offset Age-Associated Mitochondrial Deficiency With Reduced K ATP Channel Activity
  9. The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
  10. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island
  11. Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice
  12. Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
  13. ID: 21: ALTERNATIVE RAPAMYCIN TREATMENT REGIMENS MITIGATE THE IMPACT OF RAPAMYCIN ON GLUCOSE HOMEOSTASIS AND THE IMMUNE SYSTEM, AND EXTENDS LIFESPAN
  14. ID: 78: IMPROVING GLYCEMIC CONTROL THROUGH REDUCTION OF SPECIFIC DIETARY AMINO ACIDS
  15. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
  16. Rapamycin Blocks Induction of the Thermogenic Program in White Adipose Tissue
  17. Regulation of Hepatic Metabolism by the Mechanistic Target of Rapamycin
  18. Sex‐ and tissue‐specific changes in mTOR signaling with age in C57 BL /6J mice
  19. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system
  20. Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model
  21. Hot topics at the intersection of aging and energetics: Diabetes/insulin resistance, Sirtuins, and the Microbiome
  22. Metabolic Effects of Caloric Restriction
  23. mTORC2 takes the longevity stAGE
  24. Rapamycin-induced metabolic defects are reversible in both lean and obese mice
  25. Depletion of Rictor, an essential protein component of m TORC 2, decreases male lifespan
  26. RagA, but Not RagB, Is Essential for Embryonic Development and Adult Mice
  27. The Adaptor Protein p66Shc Inhibits mTOR-Dependent Anabolic Metabolism
  28. Diminished mTOR signaling: a common mode of action for endocrine longevity factors
  29. Aging
  30. The TSC-mTOR pathway regulates macrophage polarization
  31. A Central Role for mTOR in Lipid Homeostasis
  32. Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2)
  33. Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
  34. Young and old genetically heterogeneous HET 3 mice on a rapamycin diet are glucose intolerant but insulin sensitive
  35. Calorie restriction in humans inhibits the PI 3 K / AKT pathway and induces a younger transcription profile
  36. Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators
  37. Rapalogs and mTOR inhibitors as anti-aging therapeutics
  38. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake
  39. TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxO
  40. Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
  41. Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
  42. Pharmacologic Means of Extending Lifespan
  43. A Radical Role for TOR in Longevity
  44. Regulation of TOR Signaling in Mammals
  45. MSN2 and MSN4 Link Calorie Restriction and TOR to Sirtuin-Mediated Lifespan Extension in Saccharomyces cerevisiae
  46. Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival
  47. HST2 Mediates SIR2-Independent Life-Span Extension by Calorie Restriction
  48. Small molecules that regulate lifespan: evidence for xenohormesis
  49. CHAPTER 14. Extending Lifespan by Inhibiting the Mechanistic Target of Rapamycin (mTOR)